Simple Summary Gastric cancer (GC) is regarded as one of the most perilous malignancies
globally, with over one billion new cases and seven hundred and eighty-three thousand …

Background Despite the remarkable advances made in the diagnosis and treatment of
cancer during the past couple of decades, it remains the second largest cause of mortality in …

Gastrointestinal cancers are a leading cause of cancer morbidity and mortality worldwide
with 4.2 million new cases and 3.2 million deaths estimated in 2020. Despite the advances …

Gastric cancer (GC) represents~ 10% of the global cancer-related deaths, increasingly
affecting the younger population in active stages of life. The high mortality of GC is due to …

Despite the advances in cancer treatment in recent years, the development of resistance to
cancer therapy remains the biggest hurdle towards curative cancer treatments. Therefore …

Metastasis is the most important reason for the poor prognosis of gastric cancer (GC)
patients, and the mechanism urgently needs to be clarified. Here, we explored a prognostic …

Background Gastric cancer (GC) represents a major global clinical problem with very limited
therapeutic options and poor prognosis. Necroptosis, a recently discovered inflammatory …

With the booming development of precision medicine, molecular targeted therapy has been
widely used in clinical oncology treatment due to a smaller number of side effects and its …

The burdens and trends of gastric cancer are poorly understood, especially in high-
prevalence countries. Based on the Global Burden of Disease Study 2019, we analyzed the …

Long noncoding RNAs (lncRNAs) have been investigated in multiple human cancers
including gastric cancer (GC). Our research aims to explore the role of H19 in aerobic …